Bolt Biotherapeutics, Inc. (BOLT) vs Senti Biosciences, Inc. (SNTI)
- Bolt Biotherapeutics, Inc. BOLT 4.06 −4.25%
- Senti Biosciences, Inc. SNTI 0.22 −15.38%
Bolt Biotherapeutics, Inc. and Senti Biosciences, Inc. are both Biotechnology companies. Bolt Biotherapeutics, Inc. and Senti Biosciences, Inc. are of similar size ($8.2M and $8.1M). Bolt Biotherapeutics, Inc. grew revenue faster over the last twelve months: 12.8% against −70.7%. Bolt Biotherapeutics, Inc. has the higher net margin (−611.5% vs −3,789.3%) and the lower return on invested capital (−143.8% vs 0.00%). Across the 15 metrics below, Bolt Biotherapeutics, Inc. leads on 11 and Senti Biosciences, Inc. on 4.
Valuation
Profitability
| Metric | BOLT | SNTI | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (654.53%) | (4,181.12%) | 0.00% |
| Net margin | (611.47%) | (3,789.30%) | 0.00% |
| Free cash flow margin | (655.72%) | (2,900.38%) | 0.00% |
| Return on equity | (111.65%) | (466.46%) | (56.36%) |
| Return on assets | (49.62%) | (97.52%) | (48.04%) |
| Return on invested capital | (143.75%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack